Cimzia
Highmark and BCBS Share Risk on Cimzia
Highmark, a Pittsburgh-based licensee of the Blue Cross Blue Shield Association, announced it has entered into an ...
DECEMBER 2, 2020
Cimzia Receives New Indication for Moderate to Severe Plaque Psoriasis
The FDA approved a new indication for Cimzia to treat moderate to severe plaque psoriasis in adults.
MAY 30, 2018
Label Change for Cimzia: Negligible Mother-Child Transfer
Some women with chronic inflammatory diseases experience persistent moderate to high disease activity during ...
MARCH 22, 2018
Load more